GlaxoSmithKline PLC (OTC Pink - Current Information:GLAXF)

18.30
Delayed Data
As of Feb 16
 +0.24 / +1.33%
Today’s Change
16.96
Today|||52-Week Range
22.35
+3.98%
Year-to-Date
Novartis May Sell U.S. Generic Pill Business Amid Industry Struggles
Feb 16 / TheStreet.com - Paid Partner Content
Glaxo's (GSK) Begins Phase III HIV Two-Drug Regimen Study
Feb 09 / Zacks.com - Paid Partner Content
Dodge & Cox Comments on GlaxoSmithKline
Feb 13 / GuruFocus News - Paid Partner Content
Glaxo (GSK) Earnings and Revenues Surpass Estimates in Q4
Feb 08 / Zacks.com - Paid Partner Content
Dodge & Cox 4th Quarter Commentary
Feb 13 / GuruFocus News - Paid Partner Content
FDA Approves Gilead (GILD) HIV Triple Therapy, Stock Up
Feb 08 / Zacks.com - Paid Partner Content
Foreign Stock Roundup: TOT, STO & GSK Earnings Impress, BP & SNY Disappoint
Feb 12 / Zacks.com - Paid Partner Content
Glaxo (GSK) Stock Down Despite Q4 Earnings and Sales Beat
Feb 07 / Zacks.com - Paid Partner Content